EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epilepsy in Duchenne and Becker muscular dystrophies

Jesus Alfonso Armijo Gómez, Miguel A Fernandez-Garcia, Ana Camacho, Marlin Liz, Carlos Ortez, Miguel Lafuente-Hidalgo, Laura Toledo Bravo-de Laguna, Berta Estévez-Arias, Laura Carrera-García, Jessica Expósito-Escudero, Jana Domínguez-Carral iD, Andres Nascimento und 1 weitere

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52058 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Jesus Alfonso Armijo Gómez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Spain, European Union, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Duchenne and Becker muscular dystrophies (DMD and BMD) are dystrophinopathies caused by variants in DMD gene, resulting in reduced or absent dystrophin. These conditions, characterized by muscle weakness, also manifest central nervous system (CNS) comorbidities due to dystrophin expression in the CNS. Prior studies have indicated a higher prevalence of epilepsy in individuals with dystrophinopathy compared to the general population. Our research aimed to investigate epilepsy prevalence in dystrophinopathies and characterize associated electroencephalograms (EEGs) and seizures.

Methods

We reviewed 416 individuals with dystrophinopathy, followed up at three centers between 2010 and 2023, to investigate the lifetime epilepsy prevalence and characterize EEGs and seizures in those individuals diagnosed with epilepsy. Associations between epilepsy and type of dystrophinopathy, genotype, and cognitive involvement were studied.

Results

Our study revealed a higher epilepsy prevalence than the general population (1.4%; 95% confidence interval: 0.7–3.2%), but notably lower than previously reported in smaller dystrophinopathy cohorts. No significant differences were found in epilepsy prevalence between DMD and BMD or based on underlying genotypes. Cognitive impairment was not found to be linked to higher epilepsy rates. The most prevalent epilepsy types in dystrophinopathies resembled those observed in the broader pediatric population, with most individuals effectively controlled through monotherapy.

Interpretation

The actual epilepsy prevalence in dystrophinopathies may be markedly lower than previously estimated, possibly half or even less. Our study provides valuable insights into the epilepsy landscape in individuals with dystrophinopathy, impacting medical care, especially for those with concurrent epilepsy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneEpilepsyHumansMaleAdolescentFemaleAdultYoung AdultChildPrevalenceMiddle AgedChild, PreschoolElectroencephalographyComorbidityDystrophin

Substanzen

Dystrophin

Autor:innen und Institutionen

  • Neuromuscular Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Neuromuscular Unit, Hospital La Paz, Madrid, Spain.
  • Division of Pediatric Neurology, Department of Neurology, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.
  • Epilepsy Unit, Department of Neurology, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Applied Research in Neuromuscular Diseases, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
  • Center for Biomedical Research Network on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.

ORCID-Profile: Jana Domínguez-Carral, Daniel Natera-de Benito

Förderung

  • Instituto de Salud Carlos III, Spain
  • European Union
  • Instituto de Salud Carlos III
  • European Commission

Zitieren

APA

Armijo Gómez, J. A., Fernandez-Garcia, M. A., Camacho, A., Liz, M., Ortez, C., Lafuente-Hidalgo, M., Toledo Bravo-de Laguna, L., Estévez-Arias, B., Carrera-García, L., Expósito-Escudero, J., Domínguez-Carral, J., Nascimento, A., & Natera-de Benito, D. (2024). Epilepsy in Duchenne and Becker muscular dystrophies. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52058

Vancouver

Armijo Gómez JA, Fernandez-Garcia MA, Camacho A, Liz M, Ortez C, Lafuente-Hidalgo M, et al. Epilepsy in Duchenne and Becker muscular dystrophies. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52058

BibTeX
@article{ArmijoGmez2024,
  author = {Armijo Gómez, Jesus Alfonso and Fernandez-Garcia, Miguel A and Camacho, Ana and Liz, Marlin and Ortez, Carlos and Lafuente-Hidalgo, Miguel and Toledo Bravo-de Laguna, Laura and Estévez-Arias, Berta and Carrera-García, Laura and Expósito-Escudero, Jessica and Domínguez-Carral, Jana and Nascimento, Andres and Natera-de Benito, Daniel},
  title = {Epilepsy in Duchenne and Becker muscular dystrophies},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52058}
}
Kostenlos starten →